Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 4Mycoses 3Hematologic Neoplasms 3Myelodysplastic Syndromes 2Leukemia 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Neoplasms 1Mucormycosis 1Invasive Fungal Infections 1Glioma 1Glioblastoma 1Genetic Predisposition to Disease 1Candidiasis 1Breast Neoplasms 1Bone Marrow Neoplasms 1Bone Marrow Failure Disorders 1Aspergillosis 1Anemia, Aplastic 1

Interventions

Temozolomide 109Magnetic Resonance Spectroscopy 52Bevacizumab 52Radiotherapy 44Irinotecan 27Blood Specimen Collection 19Surgical Procedures, Operative 16Radiation 15Aminolevulinic Acid 15Carboplatin 13fluorodopa F 18 12Nivolumab 12Radiotherapy, Intensity-Modulated 11Carmustine 11Radiosurgery 10Magnetic Resonance Imaging 10pembrolizumab 9Topotecan 9Specimen Handling 9Everolimus 9Erlotinib Hydrochloride 9Biopsy 9poly ICLC 8Surveys and Questionnaires 8Standard of Care 8Etoposide 8Drug Therapy 8Lomustine 7Filgrastim 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioma × posaconazole × Clear all
NCT03763396 2024-03-08

Azoles Targeting Recurrent High Grade Gliomas

University Health Network, Toronto

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡